Your strategic queries, competitive analysis, and regulatory intelligence are sovereign assets. Cortex treats them that way — isolated, encrypted, and under your complete control.
No shared databases. No co-mingled processing. No cross-client exposure. Your intelligence environment is yours alone — because the moment your strategic data touches shared infrastructure, it stops being strategic.
Board-level intelligence shouldn't reach the entire organization. Role-based access ensures each person sees exactly what they need to act on — nothing more, nothing less. Access is controlled, auditable, and revocable.
When intelligence enters your decision chain without provenance, your organization inherits the risk of whatever that intelligence got wrong. Every Cortex output includes full source attribution, reasoning path, and confidence scoring.
Every access event, every document ingestion, every output delivery is logged and auditable. When regulators or compliance teams ask who saw what and when, you have the answer — instantly.
Nothing enters the system without organizational approval. Every document, every data source, every integration goes through structured governance — because ungoverned intelligence is just noise with liability attached.
Encrypted at rest. Encrypted in transit. Industry-standard protocols at every layer. Because if your intelligence infrastructure can be intercepted, it isn't intelligence — it's a liability.
No intelligence output reaches a client unless it has passed multi-model cross-verification, claim-level evidence tracing, and confidence scoring. This is not a feature — it is the architecture.
Raw signals are ingested from regulatory feeds, clinical databases, and monitored sources. Each signal receives a content hash for deduplication and a novelty score to suppress repetition. Duplicate or near-duplicate signals are flagged before entering the pipeline.
Every signal is scored across six dimensions: relevance, urgency, credibility, novelty, contradiction risk, and decision impact. Scoring is performed by a cost-efficient model (Gemini 2.5 Flash) to enable high-volume processing without budget erosion. Composite scores determine pipeline priority.
High-scoring signals are clustered into structured evidence packets containing extracted claims, entities, timestamps, and source quality scores. These packets — not raw signals — are what the generation model receives. The generator never sees unstructured input.
The primary model generates briefings or dossiers from evidence packets only. Prompts enforce evidence-only reasoning: the model must cite specific evidence for every claim. Client memory and prior context are injected to prevent repetition and ensure continuity.
A separate verifier model — from a different provider — reviews the output against the original evidence. The verifier never sees the generator's reasoning chain. It independently identifies unsupported claims, contradictions, overconfident assertions, and missing caveats. Outputs that fail verification are revised and re-verified.
Every claim in the final output is extracted, stored, and tagged with source evidence IDs, support strength, and a confidence classification: High (multi-source corroboration), Medium (single strong source), Low (limited evidence), or Blocked (contradicted by evidence). No claim reaches a client without a traceable evidence chain.
Biopharma organizations operate under FDA oversight, institutional data governance, and security audit regimes that punish failure severely. Cortex was designed from the ground up for this reality — not retrofitted from a consumer product that was never meant to hold strategic intelligence.
A data breach in biopharma doesn't just cost money. It costs regulatory standing, investor confidence, and competitive positioning that took years to build. Cortex treats security as the foundation everything else is built on — not a checkbox added after the fact.